NOVOSTE CORP /FL/·4

Aug 22, 9:20 PM ET

SACANE SCOTT 4

4 · NOVOSTE CORP /FL/ · Filed Aug 22, 2003

Insider Transaction Report

Form 4
Period: 2002-12-27
Transactions
  • Purchase

    Common Stock

    2003-01-06$7.12/sh+3,200$22,7681,657,662 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2003-01-08$7.21/sh+200$1,4431,656,162 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2002-12-31$7.28/sh+7,000$50,9601,626,062 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2002-12-31$7.18/sh+13,400$96,2011,639,462 total(indirect: See Footnote)
  • Sale

    Common Stock

    2003-01-09$7.18/sh6,900$49,5231,632,662 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2002-12-30$6.92/sh+400$2,7701,619,062 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2002-12-27$6.90/sh+5,000$34,5001,626,862 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2003-01-07$7.25/sh+4,300$31,1601,661,962 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2002-12-27$6.83/sh+7,200$49,2001,621,862 total(indirect: See Footnote)
  • Sale

    Common Stock

    2002-12-27$6.74/sh11,700$78,8561,618,662 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2003-01-02$7.24/sh+1,000$7,2401,655,462 total(indirect: See Footnote)
  • Sale

    Common Stock

    2003-01-09$7.15/sh6,800$48,6111,639,562 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2003-01-10$7.19/sh+7,000$50,3501,639,662 total(indirect: See Footnote)
  • Sale

    Common Stock

    2003-01-07$7.10/sh6,000$42,6041,655,962 total(indirect: See Footnote)
  • Sale

    Common Stock

    2003-01-08$7.15/sh9,800$70,0531,646,362 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2002-12-27$6.90/sh+3,500$24,1391,630,362 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2002-12-31$7.22/sh+15,000$108,3001,654,462 total(indirect: See Footnote)
  • Sale

    Common Stock

    2003-01-02$7.05/sh1,000$7,0501,654,462 total(indirect: See Footnote)
  • Sale

    Common Stock

    2003-01-10$7.13/sh50,000$356,4901,589,662 total(indirect: See Footnote)
Footnotes (4)
  • [F1]This Form 4 is being filed by Durus Capital Management LLC ("Capital") and Scott Sacane.
  • [F2]In accordance with instruction 4(b)(iv) of Form 4, these amounts reflect the aggregate amount of shares controlled by Capital (and by Scott Sacane through Capital) under Section 13(d) of the Exchange Act. Each Reporting Person disclaims beneficial ownership under Section 16 of the Exchange Act with respect to such transactions or securities, as applicable, to the extent greater than their indirect pecuniary interest therein.
  • [F3]Through Durus Life Sciences Master Fund Ltd.
  • [F4]The Reporting Persons are currently unable to determine the exact time of day that these transactions were effected. The Reporting Persons disclaim the applicability of Section 16 to these transactions to the extent the transactions occurred when Section 16 was inapplicable to such transactions.

Documents

2 files
  • 4
    edgar123.xmlPrimary

    FORM 4

  • EX-99

    INFORMATION REGARDING JOINT FILERS